Drug stocks advance; Elan, Antigenics soar
June 01, 2009 at 10:42 AM EDT
Drug stocks gain ground in early activity as shares of Elan Corp. soar on speculation that it could be taken over by Bristol-Myers Squibb.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.